Health TrialsbyHealthPanel

Migraine Characteristics and Associated Factors

ConditionMigraine
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLokman Hekim University

About this trial

This cross-sectional study aims to evaluate the clinical characteristics of migraine and factors associated with migraine-related disability and impact in adults diagnosed with primary migraine. Participants will complete questionnaires assessing sociodemographic and lifestyle characteristics, headache features, neck pain, sleep quality, fatigue, migraine-related disability, and the impact of headache on daily life. Migraine-related disability will be assessed using the Migraine Disability Assessment Scale (MIDAS), and headache impact will be assessed using the Headache Impact Test-6 (HIT-6). In addition, participants will undergo a physical examination including assessment of tender points. The study will investigate the relationships between migraine-related outcomes and clinical and lifestyle factors. No treatment or therapeutic intervention will be administered as part of the study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 years or older

Diagnosed with primary migraine by a neurologist

Having a history of migraine for at least 3 months

Able to understand and complete the study questionnaires and assessments

Disqualifiers

Presence of a secondary headache disorder

Presence of another neurological or systemic condition that may substantially affect headache characteristics or interfere with the study assessments

Presence of a cognitive or communication impairment that prevents reliable completion of the questionnaires

Incomplete completion of the study assessments or questionnaires

Trial population

The study population will consist of adults aged 18 years or older who have been diagnosed with primary migraine by a neurologist. Individuals who meet the study eligibility criteria and voluntarily agree to participate will be recruited through study announcements shared via social media platforms, including LinkedIn, WhatsApp, and Instagram. Eligible participants will be invited to Lokman Hekim University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, where all study assessments will be conducted face to face. The study population will include individuals with different clinical characteristics of migraine in order to evaluate migraine-related disability, headache impact, associated symptoms, lifestyle-related factors, and physical examination findings.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Observational assessment

    Other intervention

    Participants completed assessment form. No intervention was administered.

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Individuals With Primary Migraine1 intervention

Trial outcomes

Primary outcomes

1

Migraine-Related Disability

Migraine-related disability will be assessed using the Migraine Disability Assessment Scale (MIDAS). The MIDAS consists of five items evaluating the number of days over the previous 3 months in which headache caused missed or substantially reduced productivity in work/school, household activities, and family/social/leisure activities. The total score is calculated by summing the number of days reported across the five items, with higher scores indicating greater migraine-related disability.

Time frame
Baseline

Secondary outcomes

1

Headache Impact

Headache impact will be assessed using the Headache Impact Test-6 (HIT-6). The HIT-6 consists of six items evaluating the impact of headache on daily activities, fatigue, emotional well-being, and concentration. The total score ranges from 36 to 78, with higher scores indicating a greater impact of headache on daily life.

Time frame
Baseline
2

Headache Pain Intensity

Headache pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain. Higher scores indicate greater headache intensity.

Time frame
Baseline
3

Neck Pain Intensity

Neck pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain. Higher scores indicate greater neck pain intensity.

Time frame
Baseline
4

Perceived Sleep Quality

Perceived sleep quality will be assessed using a 10-cm Visual Analog Scale. Participants will rate their sleep quality from 0 to 10, with higher scores indicating better perceived sleep quality.

Time frame
Baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Lokman Hekim University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: